The Crohn’s & Colitis Foundation is collaborating with Boston University School of Medicine’s Center for Continuing Education (BU CCE) to produce a complimentary, four-session webinar series on the topic of IBD Medication Mastery.
This educational series is designed to equip both community and academic gastroenterologists with the expertise needed to optimize treatment strategies and better understand the many available treatment options. The series will be led by Dr. Sharmeel Wasan and will follow the ECHO™ model, employing a telementoring teaching format featuring actual case studies from clinical practice, in-depth group case discussions, and brief lectures by expert gastroenterologist speakers.
The four webinars will meet at 7:00 PM ET, monthly beginning in September. Practice groups as well as individual clinicians are encouraged to participate. You can learn more about the series on BU CCE’s website.
GI physicians and entire GI care teams in group practices or individually seeking practical, up-to-date IBD treatment strategies.
- Case-based, practical learning with discussion of participant cases
- Up-to-date content on new drug classes, treat-to-target strategies, combination therapy, and special populations
- Practical tools: slide sets, practice tools, patient education, online repository
- Access to IBD interprofessional specialists and national faculty
- CE/credit eligibility and ABIM MOC points
- Up to 4.0 AMA PRA Category 1 Credits™ (requires participation in all 4 sessions)
- ABIM MOC Part 2 eligibility, ANCC, ACPE, AAPA, CPE, IPCE credits (credits based on full-series participation)
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Supported by educational grants from AbbVie, Celltrion USA, Janssen Scientific Affairs, and Takeda Pharmaceuticals USA.
If you, or your clinical practice, are interested in participating, please reach out to Elizabeth Drury, from BU CCE, who can answer your questions and assist with the registration process.